on
2nd International Conference on Tumor & Cancer Immunology and Immunotherapy
July 17-18, 2017 Chicago, Illinois, USA
Home ABOUT OPEN ACCESS CONFERENCES JOURNALS FAQs BLOG CONTACT
Tumor & Cancer immunology 2017
Home
Gallery
Tumor & Cancer immunology 2017 Report

Tumor & Cancer Immunology-2017: Past Conference Report

Conference series LLC hosted the “2nd International Conference on Tumor & Cancer Immunology and Immunotherapy” during July 17-18, 2017 at Doubletree by Hilton Chicago North Shore Conference Center, 9599 Skokie Boulevard, Skokie, Illinois, 60077-1314, Chicago, USA with the theme Emerging Technologies and treatment in Tumor & Cancer immunotherapy from vaccines to antibodies and cell therapies” was a great success, where eminent keynote speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering.

Benevolent response and active participation was received from the renowned experts and Editorial Board Members of Conference series Journals as well as from the Immunologists, Scientists, Researchers, Students and Leaders in Cancer research, Tumor related research field, Immunology, who made this event successful.

The Conference was carried out through various informative and cutting edge sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Antibody Therapy of Cancer
  • Tumor Immunogenicity
  • Tumors
  • Brain Tumors
  • Immunotherapy - Tumors
  • Tumor Immunology
  • Cancer vaccines
  • Cancer Immunology & Immunotherapy
  • Immune checkpoint inhibitors
  • Cancer Research
  • Combining Cancer Immunotherapies
  • Tumor immunotherapy research
  • Cancer micro and immuno environment
  • Tumor markers and drug targeting
  • Tumorigenesis
  • Cancer clinical trials
  • Tumor biology
  • Cancer biomarkers
  • Immuno-Oncology studies
  • Immunotherapy Monitoring
  • Engineered T-Cell Therapy
  • Novel Approaches in Cancer & Tumor

The conference was embarked with an opening ceremony followed by a series of lectures delivered by Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

·         Roza Nurieva, MD Anderson Cancer Center, USA

·         Jennifer Wu, Medical University of South Carolina, USA

·         Gopal Krishnan, Promega Corporation, USA

·         Marc Delcommenne, Rush University Medical Center, USA

All the above mentioned Honorable Guests and Keynote speakers gave their energetic and fruitful contributions and special thanks to our Honorable Moderator Manal Mohamed Saber, for her remarkable contribution towards smooth functioning at Tumor & Cancer Immunology-2017 Conference.

Conference Sessions Chairs:

·         Qiao Li, University of Michigan, USA

·         Roza Nurieva, MD Anderson Cancer Center, USA

We congratulate Naoki Ohtsu, from Hokkaido University, Japan for winning Best Poster Award for the topic “Inhibition of Eva1 degrade the formation and development of glioblastomas”.

Conference Series LLC offers its heartfelt appreciation to Societies and Organizations includes Guardant Health, Crowd Reviews, Bio-equip, Bio Events, Pharma Voice and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference series LLC in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Tumor & Cancer Immunology-2017, Conference Series LLC is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, “3rd International Conference on Tumor & Cancer Immunology & Immunotherapy” to be held during September 17-18, 2018 at San Diego, USA.

 

Let us meet again @ Tumor & Cancer Immunology-2018



Expert Presentations
name

affiliation

Country
Conference Secretariat: Tumor & Cancer immunology 2017, Conference Series Conferences
5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
Tel: +1-650-268-9744, Fax: +1-650-618-1414
Toll free: 1-800-216-6499(USA & Canada),
1-800-651-097(Australia), 0805-080048(Europe)
Operated by: Editors - Journal of Immunotherapy, Journal of Immunooncology and Journal of Tumor Diagnostics and Reports
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2008-2012 Conference Series - All rights reserved